Naperol Investments turns profitable at ₹0.40 Cr PAT, margins expand sharply y/y

Naperol Investments Limited (formerly National Peroxide Limited) — now operating purely as an investment-holding company after its hydrogen-peroxide manufacturing business was demerged into separately listed National Peroxide Ltd — posted a standalone net profit of ₹0.40 Cr for Q2 FY27, a turnaround from a ₹0.01 Cr loss a year ago. Revenue from operations rose 34% YoY to ₹3.93 Cr but fell 58% QoQ from ₹9.45 Cr in Q1 FY27, since almost all of the topline is Trading-segment churn from buying/selling securities rather than a recurring operating business. There were no exceptional items in either the current or year-ago quarter, so the YoY swing to profit is the clean, as-reported number — no raw-vs-adjusted distinction is needed here. The improvement is a segment-mix story, not a scale story. The Investment segment — passive income (dividends, interest, FVTPL gains) off the company's ₹914 Cr investment book — generated ₹0.58 Cr of pre-tax profit this quarter, roughly 87% of the ₹0.66 Cr total segment result, while the Trading segment added just ₹0.08 Cr, down from ₹0.25 Cr in Q1 FY27 and versus a ₹0.02 Cr loss a year ago. Net margin (PAT/total income) expanded to ~10.2% from 1.92% in Q1 FY27 and -0.35% a year ago; operating margin (revenue less total expenses) widened to ~11.8% from 1.88% QoQ and ~1.3% YoY — both effects of this quarter's lower trading volumes needing proportionally lower stock-purchase costs, not any pricing or cost action. There is no management guidance on record and no prior concall read in our context to benchmark against — management gives no formal forward outlook — and a web search turned up no analyst or brokerage coverage of the stock, so the print cannot be checked against a street number; no company press release beyond the board-outcome letter was available for this quarter. The same November 11, 2026 board meeting that approved these results also appointed Mr. Vinay Divakar Jayade — currently CEO of group company National Peroxide Ltd — as an Additional Director, and Ms. Jinal Shah as Company Secretary, alongside a separate director's resignation on November 2, 2026; these are governance items unconnected to the quarter's numbers but consistent with ongoing board reconstitution post-demerger. Given the swing already visible between Q1 and Q2 FY27 (Trading segment revenue fell from ₹8.96 Cr to ₹3.35 Cr quarter-on-quarter), the Investment segment's steadier ₹0.49–0.66 Cr quarterly pre-tax contribution is the more consistent of the two profit sources shown in this filing.